Takeda Pharmaceutical Co Ltd ADR Cash Flow Reinvestment Rate
Takeda Pharmaceutical Co Ltd ADR cash flow reinvestment rate. Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting $55.93 Billion (capex $42.57 Billion plus investments $-13.37 Billion) from operating cash flow of $360.04 Billion. See how financially flexible is Takeda Pharmaceutical Co Ltd ADR to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Cash flow reinvestment rate of Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. Historical reinvestment intensity for Takeda Pharmaceutical Co Ltd ADR across 26 annual periods. Explore Takeda Pharmaceutical Co Ltd ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Takeda Pharmaceutical Co Ltd ADR Cash Flow Reinvestment Rate by Year (2000–2025)
Takeda Pharmaceutical Co Ltd ADR cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Takeda Pharmaceutical Co Ltd ADR. For the full cash flow conversion analysis, see TAK cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $567.86 Billion | $1.06 Trillion | $200.79 Billion | ▼ -59.3% |
| 2024 | 1.32x | $944.59 Billion | $716.34 Billion | $480.73 Billion | ▲ +3.8% |
| 2023 | 1.27x | $1.24 Trillion | $977.16 Billion | $633.69 Billion | ▲ +271.2% |
| 2022 | 0.34x | $384.16 Billion | $1.12 Trillion | $186.04 Billion | ▲ +15.9% |
| 2021 | 0.30x | $298.48 Billion | $1.01 Trillion | $236.47 Billion | ▼ -61.2% |
| 2020 | 0.76x | $509.83 Billion | $669.75 Billion | $217.71 Billion | ▼ -91.6% |
| 2019 | 9.04x | $2.97 Trillion | $328.48 Billion | $134.11 Billion | ▲ +1441.6% |
| 2018 | 0.59x | $221.60 Billion | $377.85 Billion | $128.26 Billion | ▼ -80.0% |
| 2017 | 2.94x | $767.72 Billion | $261.36 Billion | $112.03 Billion | ▼ -11.8% |
| 2016 | 3.33x | $84.86 Billion | $25.49 Billion | $84.86 Billion | ▲ +452.0% |
| 2015 | 0.60x | $110.06 Billion | $182.52 Billion | $108.72 Billion | ▲ +13.9% |
| 2014 | 0.53x | $78.52 Billion | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $95.76 Billion | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $61.90 Billion | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $124.17 Billion | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $86.96 Billion | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $39.46 Billion | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $32.62 Billion | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $29.15 Billion | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $32.09 Billion | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $53.67 Billion | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $54.16 Billion | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $33.48 Billion | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $37.52 Billion | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $26.94 Billion | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $35.42 Billion | $158.96 Billion | $35.42 Billion | — |